CI

Cigna Group
NYSE
352.40
+3.62
+1.04%
Opening 13:07 04/19 EDT
OPEN
349.43
PREV CLOSE
348.78
HIGH
352.62
LOW
348.02
VOLUME
563.11K
TURNOVER
0
52 WEEK HIGH
365.71
52 WEEK LOW
236.21
MARKET CAP
99.96B
P/E (TTM)
20.26
1D
5D
1M
3M
1Y
5Y
BUZZ-U.S. STOCKS ON THE MOVE-Ibotta, Blackstone, US health insurers
Wall Street's main stock indexes gained on Thursday. Dow Jones Industrial Average was up 0.11% at 37,793.34. Top three S&P 500 percentage gainers: Estee Lauder, United Airlines, Genuine Parts. Top two Nasdaq percentage losers: Las Vegas Sands and Tesla.
Reuters · 1d ago
BUZZ-U.S. STOCKS ON THE MOVE-Ally Financial, Zscaler, Las Vegas Sands
Dow Jones Industrial Average was up 0.52% on Thursday. The benchmark S&P 500 and the Nasdaq were subdued as higher Treasury yields pressured equities. Zscaler, Las Vegas Sands, 23andMe and Ally Financial were among the day's top stocks.
Reuters · 1d ago
BUZZ-Elevance's Q1 profit beat lifts shares of US health insurers
Shares of U.S. Health insurers rise between 1% and 4% after Elevance Health ELV.N posts upbeat Q1 profit. Higher premiums from Elevance's commercial insurance plans helped keep company's medical costs in check. UnitedHealth, Humana, Cigna and Centene all rise after the results.
Reuters · 1d ago
SHARES OF UNITED HEALTH UP 4%, CENTENE CORP UP 3.5%, HUMANA UP 1.5%, CIGNA GROUP UP ABOUT 2% AND MOLINA HEALTHCARE UP 1.8%
Reuters · 1d ago
THE CIGNA GROUP FOUNDATION ANNOUNCES NEW GRANT PROGRAM TO ADDRESS YOUTH MENTAL HEALTH CRISIS
Reuters · 1d ago
Here's Why We Think The Cigna Group's (NYSE:CI) CEO Compensation Looks Fair for the time being
The Cigna Group's total shareholder return over the past three years was 44% but earnings growth has been disappointing. CEO David Cordani has been paid US$21m in total compensation for the company. The company has reduced its earnings per share by 7.7% a year over the last three years. The group will host its Annual General Meeting on 24th of April. The total pay for CEO includes US$1.50m salary and is similar to the industry average.
Simply Wall St · 1d ago
Will Cigna (CI) Beat Estimates Again in Its Next Earnings Report?
NASDAQ · 2d ago
BUZZ-U.S. STOCKS ON THE MOVE-WiSA Technologies, Rivian Automotive, Cigna Group
The Nasdaq and the S&P 500 were muted on Tuesday as higher Treasury yields pressured equities. The blue-chip Dow bucked the trend on robust results from health insurance heavyweight UnitedHealth. The Dow Jones Industrial Average was up 0.13% at 37,783.35. UnitedHealth Group's quarterly results beat expectations.
Reuters · 3d ago
More
About CI
The Cigna Group is a global health company. The Company has two growth platforms: Evernorth Health Services and Cigna Healthcare. The Company’s portfolio of offerings solves diverse challenges across the healthcare system. Evernorth Health Services includes a range of independent and coordinated health solutions and capabilities designed to enable the healthcare system to help people live richer, healthier lives. Health plans, employers, governmental organizations and health care providers partner with Evernorth Health Services to solve their challenges in the areas of pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery and management solutions. Cigna Healthcare includes the United States healthcare and international health businesses, which provide comprehensive medical and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI) and the Company's run-off operations.

Webull offers Cigna Group stock information, including NYSE: CI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CI stock methods without spending real money on the virtual paper trading platform.